Display options
Cite
Wall GC, Krypel LL, Miller MJ, et al. A pilot study of complementary and alternative medicine use in patients with fibromyalgia syndrome. Pharm Pract (Granada). 2007;5(4):185-90doi: 10.4321/s1886-36552007000400008.
Wall, G. C., Krypel, L. L., Miller, M. J., & Rees, D. M. (2007). A pilot study of complementary and alternative medicine use in patients with fibromyalgia syndrome. Pharmacy practice, 5(4), 185-90. https://doi.org/10.4321/s1886-36552007000400008
Wall, Geoffrey C, et al. "A pilot study of complementary and alternative medicine use in patients with fibromyalgia syndrome." Pharmacy practice vol. 5,4 (2007): 185-90. doi: https://doi.org/10.4321/s1886-36552007000400008
Wall GC, Krypel LL, Miller MJ, Rees DM. A pilot study of complementary and alternative medicine use in patients with fibromyalgia syndrome. Pharm Pract (Granada). 2007 Oct;5(4):185-90. doi: 10.4321/s1886-36552007000400008. PMID: 25170357; PMCID: PMC4147799.
Copy Download .nbib Format: NLM
Share it on

Pharm Pract (Granada). 2007 Oct;5(4):185-90. doi: 10.4321/s1886-36552007000400008.

A pilot study of complementary and alternative medicine use in patients with fibromyalgia syndrome.

Pharmacy practice

Geoffrey C Wall, Linda L Krypel, Michael J Miller, Derek M Rees

Affiliations

  1. Iowa Methodist Medical Center, Drake University . Des Moines, IA ( USA ).
  2. Drake University , College of Pharmacy. Des Moines, IA ( USA ).
  3. College of Pharmac, Drake University . Des Moines, IA ( USA ).
  4. College of Pharmacy. Drake University . Des Moines, IA ( USA ).

PMID: 25170357 PMCID: PMC4147799 DOI: 10.4321/s1886-36552007000400008

Abstract

UNLABELLED: Fibromyalgia syndrome (FMS) is a complex disorder, with primary symptoms of sleep disturbances, pain, and fatigue. FMS is one of the most common reasons for patient visits to a rheumatologist. Previous studies have suggested that complementary and alternative medicine (CAM) use in patients with rheumatic diseases is common, but such data specific to FMS patients is limited.

OBJECTIVE: The following study sought to describe the prevalence of CAM use in a primary care practice of patients with FMS and assess whether these patients discuss CAM use with their physician, physician-extender, and/or pharmacist.

METHODS: A one-group cross-sectional survey design was implemented in a large, community-based, private physician practice of patients diagnosed with FMS. A self-administered questionnaire was distributed during clinic visits. It solicited information related to demographic characteristics; FMS-specific health background; whether CAM use had been discussed with a health care provider; and the "ever-use" of common types of CAM. Respondents returned the questionnaire via US mail in a postage-paid, self-addressed envelope.

RESULTS: A total of 115 surveys were distributed with 54 returned for analysis (47% completion rate). The sample was predominantly female, well educated and had a mean age of 55.6 years. All respondents were White. Most respondents (92.6%) reported using some type of CAM. Exercise (92.2%), chiropractic treatment (48.1%), lifestyle and diet (45.8%), relaxation therapy (44.9%), and dietary and herbal supplements (36.5%) were most commonly reported CAM therapies "ever-used" by respondents. Dietary and herbal supplements with the highest prevalence of "ever-use" were magnesium (19.2%), guaifenesin (11.5%), and methylsulfonylmethane (MSM) (9.6%). Respondents most commonly discussed CAM with the clinic rheumatologist and the primary care physician (53.7% and 38.9%, respectively). Only 14.8% of respondents discussed CAM with a pharmacist. However, a significantly higher proportion of respondents who "ever-used" dietary and herbal supplements discussed CAM with a pharmacist compared to those who never used dietary and herbal supplements [chi square=6.03, p=0.014].

CONCLUSION: This pilot study suggests that CAM use is common in patients diagnosed with FMS. Compared to other healthcare providers, respondents were least likely to discuss CAM with a pharmacist. However, respondents who used dietary and herbal supplements were more likely to discuss CAM with a pharmacist compared to those who did not, suggesting the potential influence of pharmacist intervention.

Keywords: Complementary Therapies; Fibromyalgia; United Stated

References

  1. Fam Pract. 2004 Aug;21(4):415-9 - PubMed
  2. J Rheumatol. 1995 May;22(5):953-8 - PubMed
  3. Arthritis Rheum. 1997 Sep;40(9):1553-5 - PubMed
  4. J Rheumatol. 1994 Jan;21(1):145-7 - PubMed
  5. Ann Intern Med. 1999 Sep 21;131(6):409-16 - PubMed
  6. Mayo Clin Proc. 2005 Jan;80(1):55-60 - PubMed
  7. Curr Rheumatol Rep. 2002 Aug;4(4):286-92 - PubMed
  8. J Am Acad Nurse Pract. 2000 Aug;12(8):311-6 - PubMed
  9. Br J Rheumatol. 1992 Jul;31(7):485-90 - PubMed
  10. Drug Saf. 2004;27(11):773-97 - PubMed
  11. J Rheumatol. 2003 Jun;30(6):1318-25 - PubMed
  12. Curr Pharm Des. 2006;12(1):47-57 - PubMed

Publication Types